Membrane instability, plasmalogen content, and Alzheimer's disease

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2533-2538

  Ginsberg, Lionel ^a   Xuereb, John H ^b   Gershfeld, Norman L ^c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Alzheimer's disease; Bilayer; Critical unilamellar state; Membrane stability; Neurodegeneration; Plasmalogens

Indexed keywords

PHOSPHATIDYLETHANOLAMINE; PLASMALOGEN;

ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID COMPOSITION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN STABILITY; TEMPERATURE MEASUREMENT;

EID: 0031745753     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062533.x     Document Type: Article

References (35)

1. Gershfeld N. L. (1986) Phospholipid surface bilayers at the air-water interface. III. Relation between surface bilayer formation and lipid bilayer assembly in cell membranes. Biophys. J. 50, 457-461.
2. Gershfeld N. L. (1989a) The critical unilamellar lipid state: a perspective for membrane bilayer assembly. Biochim. Biophys. Acta Rev. Biomembr. 988, 335-350.
3. Gershfeld N. L. (1989b) Spontaneous assembly of a phospholipid bilayer as a critical phenomenon: influence of temperature, composition and physical state. J. Phys. Chem. 93, 5256-5261.
4. Gershfeld N. L. and Ginsberg L. (1995) Membrane bilayer instability as a pathogenetic mechanism for neurological disease. Rev. Neurosci. 6, 1-13.
5. Gershfeld N. L. and Ginsberg L. (1997) Probing the critical unilamellar state of membranes. J. Memhr. Biol. 156, 279-286.
6. Ginsberg L. and Gershfeld N. L. (1991) Membrane bilayer instability and the pathogcnesis of disorders of myelin. Neurosci. Lett. 130, 133-136.
7. Ginsberg L., Gilbert D. L., and Gershfeld N. L. (1991) Membrane bilayer assembly in neural tissue of rat and squid as a critical phenomenon: influence of temperature and membrane proteins. J. Membr. Biol. 119, 65-73.
8. Ginsberg L., Atack J. R., Rapoport S. I., and Gershfeld N. L. (1993) Regional specificity of membrane instability in Alzheimer's disease brain. Brain Res. 615, 355-357.
9. Ginsberg L., Rafique S., Xuereb J. H., Rapoport S. I., and Gershfeld N. L. (1995) Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 698, 223-226.
10. Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., and Hardy J. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
11. Hirashima Y., Farooqui A. A., Murphy E. J., and Horrocks L. A. (1990) Purification of plasmalogens using Rhizopus delemar lipase and Naja-naja-naja phospholipase-A2. Lipids 25, 344-348.
12. Katzman R. (1986) Alzheimer's disease. N. Engl. J. Med. 314, 964-973.
13. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y. H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., and Tanzi R. E. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
14. Majocha R. E., Jungalwala F. B., Rodenrys A., and Marotta C. A. (1989) Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosides. J. Neurochem. 53, 953-961.
15. Miyata M. and Smith J. D. (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat. Genet. 14, 55-61.
16. Morand O. H., Zoeller R. A., and Raetz C. R. H. (1988) Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation. J. Biol. Chem. 263, 11597-11606.
17. Müller-Hill B. and Beyreuther K. (1989) Molecular biology of Alzheimer's disease. Annu. Rev. Biochem. 58, 287-307.
18. Nitsch R. M., Blusztajn J. K., Pittas A. G., Slack B. E., Growdon J. H., and Wurtman R. J. (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 89, 1671-1675.
19. Obermeyer W., Bergmann B. M., and Rechtschaffen A. (1991) Sleep deprivation in the rat. XIV. Comparison of waking hypothalamic and peritoneal temperatures. Sleep 14, 285-293.
20. O'Brien J. S. and Sampson E. L. (1965) Lipid composition of the normal human brain: gray matter, white matter and myelin. J. Lipid Res. 6, 537-544.
21. Orita T., Izumihara A., Tsurutani T., and Kajiwara K. (1995) Brain temperature before and after brain death. Neurol. Res. 17, 443-444.
22. 31P nuclear magnetic resonance study of the brain in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47, 235-248.
23. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
24. Roots B. I. and Johnston P. V. (1968) Plasmalogens of the nervous system and environmental temperature. Camp. Biochem. Physiol. 26, 553-560.
25. Roth G. S., Joseph J. A., and Mason R. P. (1995) Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci. 18, 203-206.
26. Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J., Hulette C., Crain B., Goldgaber D., and Roses A. D. (1993) Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
27. Selkoe D. J. (1994) Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 425-428.
28. Sengers J. V. (1994) Effects of critical fluctuations on the thermodynamic and transport properties of supercritical fluids, in Supercritical Fluids (Kiran E. and Levelt Sengers J. M. H., eds), pp. 231-271. KIuwer Academic, Dordrecht.
29. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
30. Skinner E. R., Watt C., Besson J. A. O., and Best P. V. (1993) Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 116, 717-725.
31. Svennerholm L. and Gottfries C.-G. (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62, 1039-1047.
32. Tajima K. and Gershfeld N. L. (1985) Phospholipid surface bilayers at the air-water interface. I. Thermodynamic properties. Biophys. J. 47, 203-209.
33. Wells K., Farooqui A. A., Liss L., and Horrocks L. A. (1995) Neural membrane phospholipids in Alzheimer disease. Neurochem. Res. 20, 1329-1333.
34. Yamaguchi H., Tanaka T., Ichioka T., Stoskopf M., Kishimoto Y., and Gould R. (1987) Characterization and composition of lipids in different squid nervous tissues. Biochim. Biophys. Acta 922, 78-84.
35. Zoeller R. A., Morand O. H., and Raetz C. R. H. (1988) A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263, 11590-11596.